Search

Your search keyword '"González Díaz, Sandra Nora"' showing total 683 results
Start Over Author "González Díaz, Sandra Nora"
683 results on '"González Díaz, Sandra Nora"'

4. Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I cross-sectional study

Author

Bissell, Karen, Chiang, Chen-Yuan, Ellwood, Eamon, Ellwood, Philippa, Marks, Guy B, Masekela, Refiloe, Morales, Eva, Mortimer, Kevin, Pearce, Neil, Strachan, David, Martinez-Torres, Antonela, Pérez-Fernández, Virginia, Robertson, Stephen, Rutter, Charlotte, Silverwood, Richard, Mallol, Javier, Soto-Martínez, Manuel, Cabrera Aguilar, Angelita, Douros, Konstantinos, Sabir, Mohammed, Singh, Meenu, Singh, Virendra, Sukumaran, Thevaruparambil Unny, Awasthi, Shally, Kabra, Sushil Kumar, Salvi, Sundeep, García-Almaráz, Roberto, Mérida-Palacio, J. Valente, Del Río Navarro, Blanca E, González-Díaz, Sandra Nora, Navarrete-Rodriguez, Elsy Maureen, Sánchez, José Félix, Falade, Adegoke G, Zar, Heather J, López-Silvarrey Varela, Angel, González Díaz, Carlos, Nour, Magde, Dib, Gazal, Mohammad, Yousser, Huang, Jing-Long, Chinratanapisit, Sasawan, Soto-Quirós, Manuel E, Vichyanond, Pakit, Aguilar, Pedro, Barba, Sergio, Kumar, Lata, Sharma, S K, Linares-Zapién, Francisco J, Onadeko, Babatunde O, Musa, Omer Abdel Aziz, Aguirre, Viviana, Baeza-Bacab, Manuel, Mohammad, Samira, Cortez, Eliana, Gratziou, Christina H, Chopra, Kamlesh, Hanumante, Neeta Milind, Nelson, Hugo, Rubio, Alfonso Delgado, Hsieh, Kue-Hsiung, Shah, Jayant, Asher, M Innes, Rutter, Charlotte E, El Sony, Asma, García-Marcos, Luis, Robertson, Steven, Silverwood, Richard J, and Strachan, David P

Published
2021
Full Text
View/download PDF

5. Update on latex allergy: New insights into an old problem

Author

Parisi, Claudio A.S., Kelly, Kevin J., Ansotegui, Ignacio J., Gonzalez-Díaz, Sandra Nora, Bilò, Maria Beatrice, Cardona, Victoria, Park, Hae-Sim, Braschi, Maria Chiara, Macias-Weinmann, Alejandra, Piga, Mario A., Acuña-Ortega, Natalhie, Sánchez-Borges, Mario, and Yañez, Anahí

Published
2021
Full Text
View/download PDF

7. Current situation of allergy education in Mexico and other parts of Latin America

Author

Gonzalez-Diaz, Sandra Nora, Martin, Bryan, de Lira-Quezada, Cindy Elizabeth, Villarreal-Gonzalez, Rosalaura Virginia, Guzman-Avilan, Rosa Ivett, Macías-Weinmann, Alejandra, Ortega-Martell, José Antonio, Macouzet-Sanchez, Carlos, Sánchez-Borges, Mario, Rosario Filho, Nelson Augusto, Yañez, Anahí, Guzman-Melendez, María Antonieta, Cardona, Ricardo, Monge-Ortega, Olga Patricia, Cherrez-Ojeda, Ivan, Herrera-Castro, Dayanara, Valentin-Rostan, Marylin, Sisul-Alvariza, Juan Carlos, Ansotegui, Ignacio J., and Elizondo-Villarreal, Barbara

Published
2021
Full Text
View/download PDF

9. Diplomacia pública digital y las estrategias implementadas por la UANL ante la pandemia por Covid 19: una revisión teórica

Author

García Waldman, David Horacio, González Díaz, Sandra Nora, García Waldman, David Horacio, and González Díaz, Sandra Nora

Abstract

El documento explora la evolución y el impacto de la digitalización en la diplomacia pública, especialmente en el contexto de la pandemia de COVID-19. Se detalla cómo la globalización y los avances tecnológicos han transformado la diplomacia pública, introduciendo nuevos métodos y estrategias digitales. Se discute el papel de las Instituciones de Educación Superior (IES), como la Universidad Autónoma de Nuevo León (UANL), en la internacionalización y la cooperación académica y científica en el marco de la diplomacia pública. El texto también aborda los desafíos y oportunidades presentados por la pandemia, resaltando cómo las restricciones impulsaron la adopción de estrategias digitales para mantener la colaboración y comunicación internacionales. Además, se enfatiza la importancia de una comunicación efectiva y el uso eficiente de la tecnología en la diplomacia pública, subrayando la necesidad de una gestión y planificación estratégica en el ámbito digital. El documento ilustra el impacto directo de la digitalización en las relaciones internacionales y la diplomacia pública, mostrando cómo la UANL y otras IES han adaptado sus estrategias para enfrentar los nuevos desafíos globales y mantener la calidad en sus actividades académicas y diplomáticas.

Published
2024

11. Doxofylline as a steroid-sparing treatment in Mexican children with asthma.

Author

González-Díaz, Sandra Nora, Ansotegui, Ignacio J., Macouzet-Sánchez, Carlos, Acuña-Ortega, Natalhie, and de la Cruz-de la Cruz, Carlos

Subjects
*ASTHMA in children, *MEXICANS, *ASTHMA, *LUNGS, *THERAPEUTICS
Abstract

The aim of this pilot study was to assess the efficacy of doxofylline as an ICS-sparing agent in the treatment of Mexican children with asthma. 10-week, open-label, crossover, pilot study, we examined the steroid-sparing effect of doxofylline in Mexican children with asthma. Patients aged 6–16 years treated with inhaled corticosteroids (ICS) for at least 8 wk before enrollment were divided randomly into two groups at the baseline visit. Group A (n = 31) received doxofylline (18 mg/kg/day) plus standard-dose budesonide (D + SDB) for the first 4-week period followed by doxofylline plus reduced-dose budesonide (D + RDB) for the second 4-week period. Group B (n = 30) received D + RDB followed by D + SDB. Clinical outcomes assessed included lung function (forced expiratory volume; in 1 s, FEV1), fractional exhaled nitric oxide (FeNO), asthma control, number of exacerbations and use of rescue medication (salbutamol). It was shown that combined use of doxofylline and ICS may allow children with asthma to reduce their daily dose of ICS while maintaining lung function and improving asthma control (p = 0.008). There were few asthma exacerbations and only one patient required treatment with systemic corticosteroids. Rescue medication use decreased significantly in patients receiving D + SDB during the first 4-week period. Our results suggest that doxofylline may be a steroid-sparing treatment in asthma, but longer-term, controlled studies are needed to confirm these observations. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

13. Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines

Author

Larenas-Linnemann, Désirée, Rodríguez-Pérez, Noel, Luna-Pech, Jorge A., Rodríguez-González, Mónica, Blandón-Vijil, María Virginia, Del-Río-Navarro, Blanca E., Costa-Domínguez, María del Carmen, Navarrete-Rodríguez, Elsy Maureen, Macouzet-Sánchez, Carlos, Ortega-Martell, José Antonio, Pozo-Beltrán, César Fireth, Estrada-Cardona, Alan, Arias-Cruz, Alfredo, Rodríguez Galván, Karen Guadalupe, Brito-Díaz, Herson, Canseco-Raymundo, María del Rosario, Castelán-Chávez, Enrique Emanuel, Escalante-Domínguez, Alberto José, Gálvez-Romero, José Luis, Gómez-Vera, Javier, González-Díaz, Sandra Nora, Guerrero-Núñez, María Gracia Belinda, Hernández-Colín, Dante Daniel, Macías-Weinmann, Alejandra, Mendoza-Hernández, David Alejandro, Meneses-Sánchez, Néstor Alejandro, Mogica-Martínez, María Dolores, Moncayo-Coello, Carol Vivian, Montiel-Herrera, Juan Manuel, O'Farril-Romanillos, Patricia María, Onuma-Takane, Ernesto, Ortega-Cisneros, Margarita, Rangel-Garza, Lorena, Stone-Aguilar, Héctor, Torres-Lozano, Carlos, Venegas-Montoya, Edna, Wakida-Kusunoki, Guillermo, Partida-Gaytán, Armando, López-García, Aída Inés, Macías-Robles, Ana Paola, Ambriz-Moreno, María de Jesús, Azamar-Jácome, Amyra Ali, Beltrán-De Paz, Claudia Yusdivia, Caballero-López, Chrystopherson, Fernández de Córdova-Aguirre, Juan Carlos, Fernández-Soto, José Roberto, Lozano-Sáenz, José Santos, Oyoqui-Flores, José Joel, Osorio-Escamilla, Roberto Efrain, Ramírez-Jiménez, Fernando, Rivero-Yeverino, Daniela, Martínez Infante, Eric, and Medina-Ávalos, Miguel Alejandro

Published
2020
Full Text
View/download PDF

15. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper

Author

Ansotegui, Ignacio J., Melioli, Giovanni, Canonica, Giorgio Walter, Caraballo, Luis, Villa, Elisa, Ebisawa, Motohiro, Passalacqua, Giovanni, Savi, Eleonora, Ebo, Didier, Gómez, R. Maximiliano, Luengo Sánchez, Olga, Oppenheimer, John J., Jensen-Jarolim, Erika, Fischer, David A., Haahtela, Tari, Antila, Martti, Bousquet, Jean J., Cardona, Victoria, Chiang, Wen Chin, Demoly, Pascal M., DuBuske, Lawrence M., Ferrer Puga, Marta, Gerth van Wijk, Roy, González Díaz, Sandra Nora, Gonzalez-Estrada, Alexei, Jares, Edgardo, Kalpaklioğlu, Ayse Füsun, Kase Tanno, Luciana, Kowalski, Marek L., Ledford, Dennis K., Monge Ortega, Olga Patricia, Morais Almeida, Mário, Pfaar, Oliver, Poulsen, Lars K., Pawankar, Ruby, Renz, Harald E., Romano, Antonino G., Rosário Filho, Nelson A., Rosenwasser, Lanny, Sánchez Borges, Mario A., Scala, Enrico, Senna, Gian-Enrico, Sisul, Juan Carlos, Tang, Mimi L.K., Thong, Bernard Yu-Hor, Valenta, Rudolf, Wood, Robert A., and Zuberbier, Torsten

Published
2020
Full Text
View/download PDF

19. Internacionalización de la educación superior para el fortalecimiento del desarrollo económico de un país

Author

González Díaz, Sandra Nora, García Waldman, David Horacio, Perales Álvarez, Alejandra, González Díaz, Sandra Nora, García Waldman, David Horacio, and Perales Álvarez, Alejandra

Abstract

Este estudio aborda la relación entre la internacionalización de la educación superior y el desarrollo económico, utilizando un enfoque cualitativo para analizar cómo la integración de estrategias de internacionalización en instituciones educativas impacta en el desarrollo económico local y global. Se examina la calidad educativa en múltiples dimensiones, destacando la importancia de la inclusión de estudiantes internacionales y la cooperación académica internacional. Las conclusiones enfatizan la relevancia de políticas educativas globalizadas y la necesidad de sistemas educativos de calidad dirigidos a áreas estratégicas para un crecimiento económico sustancial, subrayando la internacionalización como un factor crítico para fortalecer tanto la calidad educativa como las economías y sociedades modernas. Abstract This study examines the relationship between the internationalization of higher education and economic development, employing a qualitative approach to analyze how the integration of internationalization strategies in educational institutions impacts local and global economic development. It explores educational quality across multiple dimensions, emphasizing the significance of including international students and international academic cooperation. The conclusions highlight the importance of globalized ed ucational policies and the necessity for quality educational systems aimed at strategic areas for substantial economic growth, underscoring internationalization as a crucial factor in strengthening both educational quality and modern economies and societies.

Published
2023

21. Atopy, allergen sensitization and development of hypersensitivity reactions to paclitaxel.

Author

González-Díaz, Sandra Nora, Canel-Paredes, Alejandra, Macías-Weinmann, Alejandra, Vidal-Gutiérrez, Oscar, and Villarreal-González, Rosalaura Virginia

Subjects
*SKIN tests, *RISK assessment, *CANCER patients, *DESCRIPTIVE statistics, *TUMORS, *PACLITAXEL, *ALLERGIES, *DRUG allergy, *ALLERGENS, *FAMILY history (Medicine), *DISEASE risk factors, *DISEASE complications
Abstract

Background: Paclitaxel is a chemotherapeutic agent used in the treatment of multiple types of malignant tumors which was discovered from the Taxus brevofilia tree. In some patients, anaphylaxis develops during the first exposure to paclitaxel, suggesting that primary sensitization may have occurred through hidden or unidentified allergens that produce cross-reactivity. Skin testing may be useful in identifying sensitization to these allergens. Atopy has also been reported in patients with hypersensitivity reactions (HSR) to paclitaxel. The aim of this study is to evaluate the association between atopy and sensitization to allergens with the development of immediate HSR to paclitaxel. Methods: Skin prick tests (SPT) for environmental and food allergens were applied to 76 patients recently diagnosed with cancer. A SPT to paclitaxel was applied and if negative, an intradermal test was performed. After paclitaxel's infusion, the development of immediate HSR was observed. Results: Of 76 skin tests, 43% of patients had allergen sensitization and 57% did not. HSR occurred in 12.1% and 11.6% of each group, respectively. Five percent of patients tested positive to paclitaxel and only one had an immediate HSR. Eighty-nine percent of patients who developed an HSR had a family or personal history of atopy. Conclusions: Sensitization to environmental or food allergens does not appear to be a risk factor for the development of immediate HSR to paclitaxel, suggesting that there are other non-IgE-mediated immunologic mechanisms responsible for their development, however, a personal and family history of atopy increases 8x the risk of developing anaphylaxis. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

26. Contaminación ambiental y alergia

Author

González-Díaz, Sandra Nora, primary, De Lira-Quezada, Cindy Elizabeth, additional, Villarreal-González, Rosalaura Virginia, additional, and Canseco-Villarreal, José Ignacio, additional

Published
2022
Full Text
View/download PDF

28. Erratum to "IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper" [World Allergy Organ J 13/2 (2020) 100080]

Author

Ansotegui, Ignacio J., Melioli, Giovanni, Canonica, Giorgio Walter, Caraballo, Luis, Villa, Elisa, Ebisawa, Motohiro, Passalacqua, Giovanni, Savi, Eleonora, Ebo, Didier, Gómez, R.Maximiliano, Luengo Sánchez, Olga, Oppenheimer, John J., Jensen-Jarolim, Erika, Fischer, David A., Haahtela, Tari, Antila, Martti, Bousquet, Jean J., Cardona, Victoria, Chiang, Wen Chin, Demoly, Pascal M., DuBuske, Lawrence M., Ferrer Puga, Marta, Gerth van Wijk, Roy, González Díaz, Sandra Nora, Gonzalez-Estrada, Alexei, Jares, Edgardo, Kalpaklioğlu, Ayse Füsun, Kase Tanno, Luciana, Kowalski, Marek L., Ledford, Dennis K., Monge Ortega, Olga Patricia, Morais-Almeida, Mário, Pfaar, Oliver, Poulsen, Lars K., Pawankar, Ruby, Renz, Harald E., Romano, Antonino G., Rosário Filho, Nelson A., Rosenwasser, Lanny, Sánchez Borges, Mario A., Scala, Enrico, Senna, Gian-Enrico, Sisul, Juan Carlos, Tang, Mimi L.K., Yu-Hor Thong, Bernard, Valenta, Rudolf, Wood, Robert A., and Zuberbier, Torsten

Published
2021
Full Text
View/download PDF

29. Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I cross-sectional study

Author

Asher, M Innes, primary, Rutter, Charlotte E, additional, Bissell, Karen, additional, Chiang, Chen-Yuan, additional, El Sony, Asma, additional, Ellwood, Eamon, additional, Ellwood, Philippa, additional, García-Marcos, Luis, additional, Marks, Guy B, additional, Morales, Eva, additional, Mortimer, Kevin, additional, Pérez-Fernández, Virginia, additional, Robertson, Steven, additional, Silverwood, Richard J, additional, Strachan, David P, additional, Pearce, Neil, additional, Masekela, Refiloe, additional, Strachan, David, additional, Martinez-Torres, Antonela, additional, Robertson, Stephen, additional, Rutter, Charlotte, additional, Silverwood, Richard, additional, Mallol, Javier, additional, Soto-Martínez, Manuel, additional, Cabrera Aguilar, Angelita, additional, Douros, Konstantinos, additional, Sabir, Mohammed, additional, Singh, Meenu, additional, Singh, Virendra, additional, Sukumaran, Thevaruparambil Unny, additional, Awasthi, Shally, additional, Kabra, Sushil Kumar, additional, Salvi, Sundeep, additional, García-Almaráz, Roberto, additional, Mérida-Palacio, J. Valente, additional, Del Río Navarro, Blanca E, additional, González-Díaz, Sandra Nora, additional, Navarrete-Rodriguez, Elsy Maureen, additional, Sánchez, José Félix, additional, Falade, Adegoke G, additional, Zar, Heather J, additional, López-Silvarrey Varela, Angel, additional, González Díaz, Carlos, additional, Nour, Magde, additional, Dib, Gazal, additional, Mohammad, Yousser, additional, Huang, Jing-Long, additional, Chinratanapisit, Sasawan, additional, Soto-Quirós, Manuel E, additional, Vichyanond, Pakit, additional, Aguilar, Pedro, additional, Barba, Sergio, additional, Kumar, Lata, additional, Sharma, S K, additional, Linares-Zapién, Francisco J, additional, Onadeko, Babatunde O, additional, Musa, Omer Abdel Aziz, additional, Aguirre, Viviana, additional, Baeza-Bacab, Manuel, additional, Mohammad, Samira, additional, Cortez, Eliana, additional, Gratziou, Christina H, additional, Chopra, Kamlesh, additional, Hanumante, Neeta Milind, additional, Nelson, Hugo, additional, Rubio, Alfonso Delgado, additional, Hsieh, Kue-Hsiung, additional, and Shah, Jayant, additional

Published
2021
Full Text
View/download PDF

31. Current situation of allergy education in Mexico and other parts of Latin America

Author

González Díaz, Sandra Nora, Martin, Bryan, De Lira Quezada, Cindy Elizabeth, Villarreal González, Rosalaura Virginia, Guzmán Avilán, Rosa Ivett, Macías Weinmann, Alejandra, Ortega Martell, José Antonio, Macouzet Sánchez, Carlos, Sánchez Borges, Mario, Rosario Filho, Nelson Augusto, Yañez, Anahí, Guzmán Meléndez, María Antonieta, Cardona, Ricardo, Monge Ortega, Olga Patricia, Cherrez Ojeda, Ivan, Herrera Castro, Dayanara, Valentín Rostan, Marylin, Sisul Alvariza, Juan Carlos, Ansotegui, Ignacio J., Elizondo Villarreal, Bárbara, González Díaz, Sandra Nora, Martin, Bryan, De Lira Quezada, Cindy Elizabeth, Villarreal González, Rosalaura Virginia, Guzmán Avilán, Rosa Ivett, Macías Weinmann, Alejandra, Ortega Martell, José Antonio, Macouzet Sánchez, Carlos, Sánchez Borges, Mario, Rosario Filho, Nelson Augusto, Yañez, Anahí, Guzmán Meléndez, María Antonieta, Cardona, Ricardo, Monge Ortega, Olga Patricia, Cherrez Ojeda, Ivan, Herrera Castro, Dayanara, Valentín Rostan, Marylin, Sisul Alvariza, Juan Carlos, Ansotegui, Ignacio J., and Elizondo Villarreal, Bárbara

Abstract

Allergic diseases are one of the most frequent chronic diseases in the world. It has been established that there is a worldwide epidemic of allergic diseases; therefore, the treatment of allergies should be acknowledged as a worldwide priority and the specialty of allergy should be considered an important field in medicine. Due to the fact that allergic diseases involve many organs, and Allergy and Clinical Immunology is one of the specialties in which physicians may be trained to treat patients of all ages, the subject in medical schools is not always taught as an individual specialty but often as part of another subject such as internal medicine or pediatrics. Certified allergists are an important contribution to health systems, providing the necessary care for patients who have allergic diseases. Undergraduate programs in many universities do not include allergy as a subject, contributing to a lack of knowledge regarding the correct management of allergic diseases. World Health Organization (WHO) recommends 1 allergist per 50,000 people; however, there is an uneven distribution of allergy and clinical immunology specialists. Most practitioners are localized mainly in larger cities and state capitals, while in other regions, specialists are still greatly needed. Support and training systems are required for allergy and clinical immunology specialists to promote continuing education and keep their clinical competence up to date, which will lead to better care for their patients. Increased exposure to the concepts of allergy and clinical immunology diagnosis and treatment in undergraduate education may also potentially lead to an increase in interest in the field of allergy and clinical immunology among physicians in training. This review will approach allergy education in Mexico and other parts of Latin America.

Published
2021

32. Allergy and coronavirus disease (COVID-19) international survey: Real-life data from the allergy community during the pandemic

Author

Tanno, Luciana Kase, Demoly, Pascal, Martin, Bryan, Berstein, Jonathan, Morais Almeida, Mario, Levin, Michael, Fiocchi, Alessandro, Sánchez Borges, Mario, Caraballo, Luis R., Wong, Gary, Ortega Martell, José Antonio, Rouadi, Philip W., Yáñez, Anahí, Wang, Liang Lu, Peden, David B., Chikhladze, Manana, González Díaz, Sandra Nora, Fontaine, Jean-François, Sublett, James L., Chang, Yoon-Seok, Passalacqua, Giovanni, Ansotegui, Ignacio J., Ebisawa, Motohiro, Senna, Gianenrico, Caminati, Marco, Tanno, Luciana Kase, Demoly, Pascal, Martin, Bryan, Berstein, Jonathan, Morais Almeida, Mario, Levin, Michael, Fiocchi, Alessandro, Sánchez Borges, Mario, Caraballo, Luis R., Wong, Gary, Ortega Martell, José Antonio, Rouadi, Philip W., Yáñez, Anahí, Wang, Liang Lu, Peden, David B., Chikhladze, Manana, González Díaz, Sandra Nora, Fontaine, Jean-François, Sublett, James L., Chang, Yoon-Seok, Passalacqua, Giovanni, Ansotegui, Ignacio J., Ebisawa, Motohiro, Senna, Gianenrico, and Caminati, Marco

Abstract

Background: The COVID-19 outbreak brought an unprecedented challenge to the world. Knowledge in the field has been increasing exponentially and the main allergy societies have produced guidance documents for better management of allergic patients during this period. However, few publications so far have provided real-life data from the allergy community concerning allergy practice during the COVID-19 outbreak. Therefore, we proposed an international survey on the management of allergic patients during the current pandemic. Methods: We performed an online survey undertaken to reach out the worldwide allergy community by e-mail and social media. The web-based questionnaire contained 24 questions covering demographic data from the participants, clinical practice during this period, and questions related to the new international classification and coding tools addressed for COVID-19. It was circulated for 8 weeks and had anonymous and volunteer context. Results: Data are presented for 635 participants from 78 countries of all continents. Allergists with long-term professional experience were the main audience. As expected, we received many responses as “I have no data” or “I don’t know” to the questions of the survey. However, most with more experience on managing allergic patients during the pandemic agreed that patients suffering from allergic or hypersensitivity conditions have no increased risk of contracting COVID19 or developing SARS CoV-2. Also, participants mentioned that none of the allergy treatments (inhaled corticosteroids, allergen immunotherapy, biological agents) increased the risk of contracting COVID-19 infection including severe presentations. Conclusion: The data presented are a starting point in the process of getting feedback on all the recommendations provided by the allergy societies; it could also be the basis of new strategies to support health professionals while new COVID-19 specific treatments and vaccines are being explored. The information

Published
2021

33. Psychological impact of the COVID-19 pandemic on patients with allergic diseases

Author

González Díaz, Sandra Nora, Martin, Bryan, Villarreal González, Rosalaura Virginia, De Lira Quezada, Cindy Elizabeth, Macouzet Sánchez, Carlos, Macías Weinmann, Alejandra, Guzmán Avilán, Rosa Ivett, García Campa, Mariano, Noyola Pérez, Andrés, García González, David Uriel, González Díaz, Sandra Nora, Martin, Bryan, Villarreal González, Rosalaura Virginia, De Lira Quezada, Cindy Elizabeth, Macouzet Sánchez, Carlos, Macías Weinmann, Alejandra, Guzmán Avilán, Rosa Ivett, García Campa, Mariano, Noyola Pérez, Andrés, and García González, David Uriel

Abstract

On March 2020, WHO declared COVID-19 as a pandemic disease. Interactions between allergy-related inflammatory and psychiatric disorders including depression, anxiety and posttraumatic stress disorder (PTSD) have been documented. Therefore, those who have pre-existing allergic conditions may have an increased psychiatric reaction to the stresses of the COVID-19 pandemic. Objective Identify the psychological impact of COVID-19 in patients with allergic diseases and determine if these individuals have a greater risk of presenting with post-traumatic stress disorder (PTSD). Methods It is a cross-sectional, survey-based study designed to assess the degree of symptoms of depression and the risk of PTSD using the Patient Health Questionnaire (PHQ-9) and the Impact of Event Scale–Revised (IES-R), respectively in allergic patients. Results A total of 4,106 surveys were evaluated; 1,656 (40.3%) were patients with allergic disease, and 2,450 (59.7%) were non-allergic (control) individuals. Of those with allergies, 76.6% had respiratory allergic disease including asthma and allergic rhinitis. Individuals with allergic disease reported higher scores regarding symptoms of PTSD on the IES-R scale (p = 0.052, OR 1.24 CI .99 - 1.55) as well as a higher depression risk score in the PHQ-9 questionnaire (mean 6.82 vs. 5.28) p = 0.000 z = -8.76. The allergy group presented a higher score in the IES-R questionnaire (mean 25.42 vs. 20.59), being more susceptible to presenting PTSD (p = 0.000, z = -7.774). The individuals with allergic conditions were further divided into subgroups of those with respiratory allergies such as allergic rhinitis and asthma vs those with non-respiratory allergies such as drug and food allergy, urticaria and atopic dermatitis. This subgroup analysis compares respiratory versus non-respiratory allergic patients, with similar results on the IES-R (mean 25.87 vs 23.9) p = 0.0124, z = -1.539. There was no significant difference on intrusion (p=0.061, z=-1.873) and

Published
2021

35. Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines

Author

Larenas Linnemann, Désirée, Rodríguez Pérez, Noel, Luna Pech, Jorge A., Rodríguez González, Mónica, Blandón Vijil, María Virginia, Del Río Navarro, Blanca E., Costa Domínguez, María del Carmen, Navarrete Rodríguez, Elsy Maureen, Macouzet Sánchez, Carlos, Ortega Martell, José Antonio, Pozo Beltrán, César Fireth, Estrada Cardona, Alan, Arias Cruz, Alfredo, Rodríguez Galván, Karen Guadalupe, Brito Díaz, Herson, Canseco Raymundo, María Del Rosario, Castelán Chávez, Enrique Emanuel, Escalante Domínguez, Alberto José, Gálvez Romero, José Luis, Gómez Vera, Javier, González Díaz, Sandra Nora, Guerrero Núñez, María Gracia Belinda, Hernández Colín, Dante Daniel, Macías Weinmann, Alejandra, Mendoza Hernández, David Alejandro, Meneses Sánchez, Néstor Alejandro, Mogica Martínez, María Dolores, Moncayo Coello, Carol Vivian, Montiel Herrera, Juan Manuel, O'Farril Romanillos, Patricia María, Onuma Takane, Ernesto, Ortega Cisneros, Margarita, Rangel Garza, Lorena, Stone Aguilar, Héctor, Torres Lozano, Carlos, Venegas Montoya, Edna, Wakida Kusunoki, Guillermo, Partida Gaytán, Armando, López García, Aída Inés, Macías Robles, Ana Paola, Ambriz Moreno, María de Jesús, Azamar Jácome, Amyra Ali, Beltrán de Paz, Claudia Yusdivia, Caballero López, Chrystopherson, Fernández de Córdova Aguirre, Juan Carlos, Fernández Soto, José Roberto, Lozano Sáenz, José Santos, Oyoqui Flores, José Joel, Osorio Escamilla, Roberto Efrain, Ramírez Jiménez, Fernando, Rivero Yeverino, Daniela, Martínez Infante, Eric, Medina Ávalos, Miguel Alejandro, Larenas Linnemann, Désirée, Rodríguez Pérez, Noel, Luna Pech, Jorge A., Rodríguez González, Mónica, Blandón Vijil, María Virginia, Del Río Navarro, Blanca E., Costa Domínguez, María del Carmen, Navarrete Rodríguez, Elsy Maureen, Macouzet Sánchez, Carlos, Ortega Martell, José Antonio, Pozo Beltrán, César Fireth, Estrada Cardona, Alan, Arias Cruz, Alfredo, Rodríguez Galván, Karen Guadalupe, Brito Díaz, Herson, Canseco Raymundo, María Del Rosario, Castelán Chávez, Enrique Emanuel, Escalante Domínguez, Alberto José, Gálvez Romero, José Luis, Gómez Vera, Javier, González Díaz, Sandra Nora, Guerrero Núñez, María Gracia Belinda, Hernández Colín, Dante Daniel, Macías Weinmann, Alejandra, Mendoza Hernández, David Alejandro, Meneses Sánchez, Néstor Alejandro, Mogica Martínez, María Dolores, Moncayo Coello, Carol Vivian, Montiel Herrera, Juan Manuel, O'Farril Romanillos, Patricia María, Onuma Takane, Ernesto, Ortega Cisneros, Margarita, Rangel Garza, Lorena, Stone Aguilar, Héctor, Torres Lozano, Carlos, Venegas Montoya, Edna, Wakida Kusunoki, Guillermo, Partida Gaytán, Armando, López García, Aída Inés, Macías Robles, Ana Paola, Ambriz Moreno, María de Jesús, Azamar Jácome, Amyra Ali, Beltrán de Paz, Claudia Yusdivia, Caballero López, Chrystopherson, Fernández de Córdova Aguirre, Juan Carlos, Fernández Soto, José Roberto, Lozano Sáenz, José Santos, Oyoqui Flores, José Joel, Osorio Escamilla, Roberto Efrain, Ramírez Jiménez, Fernando, Rivero Yeverino, Daniela, Martínez Infante, Eric, and Medina Ávalos, Miguel Alejandro

Abstract

Background: Allergen immunotherapy (AIT) has a longstanding history and still remains the only disease-changing treatment for allergic rhinitis and asthma. Over the years 2 different schools have developed their strategies: the United States (US) and the European. Allergen extracts available in these regions are adapted to local practice. In other parts of the world, extracts from both regions and local ones are commercialized, as in Mexico. Here, local experts developed a national AIT guideline (GUIMIT 2019) searching for compromises between both schools. Methods: Using ADAPTE methodology for transculturizing guidelines and AGREE-II for evaluating guideline quality, GUIMIT selected 3 high-quality Main Reference Guidelines (MRGs): the European Academy of Allergy, Asthma and Immunology (EAACI) guideines, the S2k guideline of various German-speaking medical societies (2014), and the US Practice Parameters on Allergen Immunotherapy 2011. We formulated clinical questions and based responses on the fused evidence available in the MRGs, combined with local possibilities, patient's preference, and costs. We came across several issues on which the MRGs disagreed. These are presented here along with arguments of GUIMIT members to resolve them. GUIMIT (for a complete English version, see Supplementary data) concluded the following: Results: Related to the diagnosis of IgE-mediated respiratory allergy, apart from skin prick testing complementary tests (challenges, in vitro testing and molecular such as species-specific allergens) might be useful in selected cases to inform AIT composition. AIT is indicated in allergic rhinitis and suggested in allergic asthma (once controlled) and IgE-mediated atopic dermatitis. Concerning the correct subcutaneous AIT dose for compounding vials according to the US school: dosing tables and formula are given; up to 4 non-related allergens can be mixed, refraining from mixing high with low protease extracts. When using European extracts: the man

Published
2020

36. Medical devices in allergy practice

Author

Popov, Todor A., Passalacqua, Giovanni, González Díaz, Sandra Nora, Plavec, Davor, Braido, Fulvio, García Abujeta, Jose Luis, Dubuske, Lawrence, Rouadi, Philip W., Morais Almeida, Mario, Bonini, Sergio, Cheng, Lei, Ansotegui, Ignacio J., Popov, Todor A., Passalacqua, Giovanni, González Díaz, Sandra Nora, Plavec, Davor, Braido, Fulvio, García Abujeta, Jose Luis, Dubuske, Lawrence, Rouadi, Philip W., Morais Almeida, Mario, Bonini, Sergio, Cheng, Lei, and Ansotegui, Ignacio J.

Abstract

Medical devices provide people with some health benefits in terms of diagnosis, prevention, treatment, and monitoring of disease processes. Different medical specialties use varieties of medical devices more or less specific for them. Allergology is an interdisciplinary field of medical science and teaches that allergic reactions are of systemic nature but can express themselves at the level of different organs across the life cycle of an individual. Subsequently, medical devices used in allergology could be regarded as: 1) general, servicing the integral diagnostic and management principles and features of allergology, and 2) organ specific, which are shared by organ specific disciplines like pulmonology, otorhinolaryngology, dermatology, and others. The present position paper of the World Allergy Organization (WAO) is meant to be the first integral document providing structured information on medical devices in allergology used in daily routine but also needed for sophisticated diagnostic purposes and modern disease management. It is supposed to contribute to the transformation of the health care system into integrated care pathways for interrelated comorbidities.

Published
2020

37. Desensibilización rápida a tocilizumab en artritis idiopática juvenil sistémica

Author

Villarreal González, Rosalaura Virginia, González Díaz, Sandra Nora, De Lira Quezada, Cindy Elizabeth, Macías Weinmann, Alejandra, Acuña Ortega, Natalhie, Villarreal González, Rosalaura Virginia, González Díaz, Sandra Nora, De Lira Quezada, Cindy Elizabeth, Macías Weinmann, Alejandra, and Acuña Ortega, Natalhie

Published
2020

38. COVID-19, asthma, and biological therapies: What we need to know

Author

Morais Almeida, Mario, Aguiar, Rita, Martin, Bryan, Ansotegui, Ignacio J., Ebisawa, Motohiro, Arruda, L. Karla, Caminati, Marco, Canonica, Giorgio Walter, Carr, Tara, Chupp, Geoffrey, Corren, Jonathan, Dávila, Ignacio, Park, Hae-Sim, Hanania, Nicola A., Rosenwasser, Lanny, Sánchez Borges, Mario, Virchow, J. Christian, Yáñez, Anahí, Bernstein, Jonathan A., Caraballo, Luis, Chang, Yoon-Seok, Chikhladze, Manana, Fiocchi, Alessandro, González Díaz, Sandra Nora, Tanno, Luciana Kase, Levin, Michael, Ortega Martell, José Antonio, Passalacqua, Giovanni, Peden, David B., Rouadi, Philip W., Sublett, James L., Wong, Gary W.K., Bleecker, Eugene R., Morais Almeida, Mario, Aguiar, Rita, Martin, Bryan, Ansotegui, Ignacio J., Ebisawa, Motohiro, Arruda, L. Karla, Caminati, Marco, Canonica, Giorgio Walter, Carr, Tara, Chupp, Geoffrey, Corren, Jonathan, Dávila, Ignacio, Park, Hae-Sim, Hanania, Nicola A., Rosenwasser, Lanny, Sánchez Borges, Mario, Virchow, J. Christian, Yáñez, Anahí, Bernstein, Jonathan A., Caraballo, Luis, Chang, Yoon-Seok, Chikhladze, Manana, Fiocchi, Alessandro, González Díaz, Sandra Nora, Tanno, Luciana Kase, Levin, Michael, Ortega Martell, José Antonio, Passalacqua, Giovanni, Peden, David B., Rouadi, Philip W., Sublett, James L., Wong, Gary W.K., and Bleecker, Eugene R.

Abstract

Managing patients with severe asthma during the coronavirus pandemic and COVID-19 is a challenge. Authorities and physicians are still learning how COVID-19 affects people with underlying diseases, and severe asthma is not an exception. Unless relevant data emerge that change our understanding of the relative safety of medications indicated in patients with asthma during this pandemic, clinicians must follow the recommendations of current evidence-based guidelines for preventing loss of control and exacerbations. Also, with the absence of data that would indicate any potential harm, current advice is to continue the administration of biological therapies during the COVID-19 pandemic in patients with asthma for whom such therapies are clearly indicated and have been effective. For patients with severe asthma infected by SARS-CoV-2, the decision to maintain or postpone biological therapy until the patient recovers should be a case-by-case based decision supported by a multidisciplinary team. A registry of cases of COVID-19 in patients with severe asthma, including those treated with biologics, will help to address a clinical challenge in which we have more questions than answers.

Published
2020

39. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper

Author

Ansotegui, Ignacio J, Melioli, Giovanni, Canonica, Giorgio Walter, Caraballo, Luis, Villa, Elisa, Ebisawa, Motohiro, Passalacqua, Giovanni, Savi, Eleonora, Ebo, Didier, Gómez, R Maximiliano, Luengo Sánchez, Olga, Oppenheimer, John J, Jensen-Jarolim, Erika, Fischer, David A, Haahtela, Tari, Antila, Martti, Bousquet, Jean J, Cardona, Victoria, Demoly, Pascal M, DuBuske, Lawrence M, Ferrer Puga, Marta, Gerth van Wijk, Roy, González Díaz, Sandra Nora, Gonzalez-Estrada, Alexei, Jares, Edgardo, Kalpaklioğlu, Ayse Füsun, Kase Tanno, Luciana, Kowalski, Marek L, Ledford, Dennis K, Monge Ortega, Olga Patricia, Morais Almeida, Mário, Pfaar, Oliver, Poulsen, Lars K, Pawankar, Ruby, Renz, Harald E, Romano, Antonino G, Rosário Filho, Nelson A, Rosenwasser, Lanny, Sánchez Borges, Mario A, Scala, Enrico, Senna, Gian-Enrico, Sisul, Juan Carlos, Tang, Mimi L K, Thong, Bernard Yu-Hor, Valenta, Rudolf, Wood, Robert A, Zuberbier, Torsten, Ansotegui, Ignacio J, Melioli, Giovanni, Canonica, Giorgio Walter, Caraballo, Luis, Villa, Elisa, Ebisawa, Motohiro, Passalacqua, Giovanni, Savi, Eleonora, Ebo, Didier, Gómez, R Maximiliano, Luengo Sánchez, Olga, Oppenheimer, John J, Jensen-Jarolim, Erika, Fischer, David A, Haahtela, Tari, Antila, Martti, Bousquet, Jean J, Cardona, Victoria, Demoly, Pascal M, DuBuske, Lawrence M, Ferrer Puga, Marta, Gerth van Wijk, Roy, González Díaz, Sandra Nora, Gonzalez-Estrada, Alexei, Jares, Edgardo, Kalpaklioğlu, Ayse Füsun, Kase Tanno, Luciana, Kowalski, Marek L, Ledford, Dennis K, Monge Ortega, Olga Patricia, Morais Almeida, Mário, Pfaar, Oliver, Poulsen, Lars K, Pawankar, Ruby, Renz, Harald E, Romano, Antonino G, Rosário Filho, Nelson A, Rosenwasser, Lanny, Sánchez Borges, Mario A, Scala, Enrico, Senna, Gian-Enrico, Sisul, Juan Carlos, Tang, Mimi L K, Thong, Bernard Yu-Hor, Valenta, Rudolf, Wood, Robert A, and Zuberbier, Torsten

Abstract

Currently, testing for immunoglobulin E (IgE) sensitization is the cornerstone of diagnostic evaluation in suspected allergic conditions. This review provides a thorough and updated critical appraisal of the most frequently used diagnostic tests, both in vivo and in vitro. It discusses skin tests, challenges, and serological and cellular in vitro tests, and provides an overview of indications, advantages and disadvantages of each in conditions such as respiratory, food, venom, drug, and occupational allergy. Skin prick testing remains the first line approach in most instances; the added value of serum specific IgE to whole allergen extracts or components, as well as the role of basophil activation tests, is evaluated. Unproven, non-validated, diagnostic tests are also discussed. Throughout the review, the reader must bear in mind the relevance of differentiating between sensitization and allergy; the latter entails not only allergic sensitization, but also clinically relevant symptoms triggered by the culprit allergen.

Published
2020

40. Staph's Toxins IgE Antibodies and Its Relation to the Severity of Allergic Rhinitis.

Author

Guzmán-Avilán, Rosa Ivett, González-Díaz, Sandra Nora, Guzmán-Avilán, Katia Denisse, De la Cruz-De la Cruz, Carlos De la Cruz-, de León-Gutiérrez, Humberto, and Guzmán-López, Santos

Subjects
ALLERGIC rhinitis, IMMUNOGLOBULIN E, TOXINS, IMMUNOGLOBULINS, CLINICAL immunology
Abstract

Background: Specific IgE against Staphylococcus can be found in approximately 40% of patients with allergies, also in patients without allergies because they may be sensitized. These antibodies are functional, and they can induce histamine release contributing to chronic pruritus which can worsen disease severity. The objective of this study was to compare levels of specific IgE against S. aureus toxins in those populations. Methods: A cross-sectional, comparative non-blinded survey was made at the Regional Center for Allergy and Clinical Immunology. Ninety-nine adults between 18 and 70 years of age with allergic rhinitis (AR) and without allergic rhinitis (wAR) were recruited. A clinical history and demographic data, and allergic sensitization patterns to 35 aeroallergens were obtained, and participants were classified according to their severity using the Allergic Rhinitis and Its Impact on Asthma (ARIA) classification. Specific IgE levels were determined using ImmunoCAP™ 100 platform. Results: The median age (IQR) of the participants was 23 (20– 33.7); 56.2% were women. The most frequent comorbidities were asthma and obesity. Of the patients with AR, 46.7% were classified as mild intermittent and 25% as moderate persistent. IgE levels against staph toxins A, B, and TSST were significantly higher in the AR group vs the wAR group [median IQR 0.01 (0.01– 0.03) vs. 0.01 (0– 0.02), p = 0.01; 0.02 (0.01– 0.03) vs. 0.01 (0– 0.02), p= 0.02; 0.04 (0.02– 0.09) vs. 0.01 (0– 0.04), p=0.002, respectably]. A significant difference was found in serum IgE levels against Staph B toxin between severity subgroups. Conclusion: People with AR have higher IgE levels against staph toxins A, B and TSST than wAR subjects. However, it is not possible declare that the IgE titers were related to disease severity. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

42. Alergia al látex: una revisión sobre los aspectos más importantes.

Author

González-Díaz, Sandra Nora, Macías-Weinmann, Alejandra, Hernández-Robles, Maricela, and Acuña-Ortega, Natalhie

Abstract

This allergy is a hypersensitivity reaction that is triggered by contact with latex. Symptoms vary depending on factors such as route, frequency, and exposure dose, as well as individual susceptibility. The clinical manifestations can be localized at the site of contact with latex or generalized. Exposure can occur directly as a result of contact with the skin and mucous membranes, that is by touching or being touched by objects with latex, or by inhaling (breathing) particles from objects with latex. Contact can also be indirect; for example, by ingesting food that has been handled by a worker wearing latex gloves or by having contact with a person who has been blowing up balloons. The diagnosis of latex allergy is made based on the patient's medical history and on what has been reported in the interrogation, and it is complemented with in vivo studies (such as skin tests and provocation tests) or in vitro studies (determination of specific IgE). The fundamental pillar in the treatment of latex allergy is the education of the patient to achieve the avoidance of products made with this material or the contact and intake of food that has had contact with latex. In view of the foregoing, latex allergy has a great medical and social relevance due to all the safety measures that the patient must take. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

43. Contaminación ambiental y alergia.

Author

González-Díaz, Sandra Nora, de Lira-Quezada, Cindy Elizabeth, Villarreal-González, Rosalaura Virginia, and Canseco-Villarreal, José Ignacio

Abstract

Air pollution, climate change, and the decrease of biological diversity are major threats to human health. In the past decades, an increase in allergic diseases, including asthma and rhinoconjunctivitis, has been observed. Up to 40 % of the world population may have an allergic disease, which represents a significant impact on the quality of life of those who suffer from it, and environmental pollution is one of the causes of its presentation. Air pollution causes significant morbidity and mortality in patients with inflammatory airway diseases such as allergic rhinitis, chronic rhinosinusitis, asthma, and chronic obstructive pulmonary disease. Oxidative stress in patients with respiratory diseases can induce eosinophilic inflammation in the airways, increase atopic allergic sensitization, and rise susceptibility to infections. Climate change has influenced exposure to extramural allergens and it is associated with exacerbations of respiratory diseases in the upper and lower airway. The interaction of indoor and outdoor environmental exposure and host factors can affect the development and progression of lifelong allergic diseases. The decrease of exposure to air pollutants has been associated with a favorable response in respiratory health, which is why it is necessary to implement measures that contribute to an improvement in air quality. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

44. Guía de actuación en anafilaxia en Latinoamérica. Galaxia-Latam

Author

Cardona, Victoria, Alvarez Perea, Alberto, Ansotegui Zubeldia, Ignacio Javier, Arias Cruz, Alfredo, Ivancevich, Juan Carlos, González Díaz, Sandra Nora, Latour Staffeld, Patricia, Sánchez Borges, Mario, Serrano, Carlos D., Solé, Dirceu, Tanno, Luciana Kase, Cabañes Higuero, Nieves, Chivato, Tomás, De la Hoz, Belén, Fernández Rivas, Montserrat, Gangoiti, Iker, Guardia Martínez, Pedro, Herranz Sanz, Miguel Ángel, Juliá Benito, Juan Carlos, Lobera Labairu, Teófilo, Praena Crespo, Manuel, Prieto Romo, José Ignacio, Sánchez Salguero, Carlos, Sánchez González, José Ignacio, Uixera Marzal, Sonia, Vega, Arantza, Villarroel, Pedro, Jares, Edgardo José, Cardona, Victoria, Alvarez Perea, Alberto, Ansotegui Zubeldia, Ignacio Javier, Arias Cruz, Alfredo, Ivancevich, Juan Carlos, González Díaz, Sandra Nora, Latour Staffeld, Patricia, Sánchez Borges, Mario, Serrano, Carlos D., Solé, Dirceu, Tanno, Luciana Kase, Cabañes Higuero, Nieves, Chivato, Tomás, De la Hoz, Belén, Fernández Rivas, Montserrat, Gangoiti, Iker, Guardia Martínez, Pedro, Herranz Sanz, Miguel Ángel, Juliá Benito, Juan Carlos, Lobera Labairu, Teófilo, Praena Crespo, Manuel, Prieto Romo, José Ignacio, Sánchez Salguero, Carlos, Sánchez González, José Ignacio, Uixera Marzal, Sonia, Vega, Arantza, Villarroel, Pedro, and Jares, Edgardo José

Published
2019

45. Evaluation Of Clinical Changes In Pediatric Patients With Atopic Dermatitis And Respiratory Allergy Receiving Allergen-specific Immunotherapy

Author

Elizabeth de Lira Quezada, Cindy, Arias Cruz, Alfredo, González Díaz, Sandra Nora, Román Cañamar, David Eugenio, Villarreal González, Rosalaura Virginia, Sánchez Guerra, Daniel, Elizabeth de Lira Quezada, Cindy, Arias Cruz, Alfredo, González Díaz, Sandra Nora, Román Cañamar, David Eugenio, Villarreal González, Rosalaura Virginia, and Sánchez Guerra, Daniel

Published
2019

46. Drug Induced Anaphylaxis, Elicitors, Risk Factors and Management in Latin America

Author

Jares, Edgardo José, Cardona Villa, Ricardo, Sánchez Borges, Mario, Falco, Alicia de, Ensina, Luis Felipe C., Bernstein, Jonathan A., Arias Cruz, Alfredo, Cherrez Ojeda, Iván, Morfín Maciel, Blanca María, Macías Weinmann, Alejandra, González Díaz, Sandra Nora, Solé, Dirceu, Giavina Bianchi, Pedro, Barayazarra, Susana, Cuello, Mabel Noemi, Vinuesa, Miguel Ángel, Calderón, Juan Carlos, Zanacchi, Viviana A., Monsell, Silvana Beatriz, Rocha Félix, Mara Morelo, Serrano Reyes, Carlos, Piraino, Pedro, Jaller, Rodolfo, Ayres Bastos, Patricia Guerzet, Gómez, Maximiliano, Jares, Edgardo José, Cardona Villa, Ricardo, Sánchez Borges, Mario, Falco, Alicia de, Ensina, Luis Felipe C., Bernstein, Jonathan A., Arias Cruz, Alfredo, Cherrez Ojeda, Iván, Morfín Maciel, Blanca María, Macías Weinmann, Alejandra, González Díaz, Sandra Nora, Solé, Dirceu, Giavina Bianchi, Pedro, Barayazarra, Susana, Cuello, Mabel Noemi, Vinuesa, Miguel Ángel, Calderón, Juan Carlos, Zanacchi, Viviana A., Monsell, Silvana Beatriz, Rocha Félix, Mara Morelo, Serrano Reyes, Carlos, Piraino, Pedro, Jaller, Rodolfo, Ayres Bastos, Patricia Guerzet, and Gómez, Maximiliano

Published
2019

47. Outcome measures to be considered on asthma in elderly

Author

González Díaz, Sandra Nora, Villarreal González, Rosalaura Virginia, De Lira Quezada, Cindy Elizabeth, Guzmán Avilán, Rosa Ivett, González Díaz, Sandra Nora, Villarreal González, Rosalaura Virginia, De Lira Quezada, Cindy Elizabeth, and Guzmán Avilán, Rosa Ivett

Abstract

El asma en pacientes mayores de 65 años tiene un impacto negativo importante en la calidad de vida. La fisiopatología y el tratamiento del asma en pacientes de edad avanzada no están tan bien identificados como en grupos de edades más jóvenes. En esta revisión pretendemos marcar las características encontradas en adultos mayores, que los distinguen de otros grupos de edad de pacientes con asma.

Published
2019

48. Importancia de los centros de excelencia de la Organización Mundial de Alergia

Author

Sánchez Borges, Mario, González Díaz, Sandra Nora, Rosenwasser, Lanny, Ansotegui, Ignacio J., Sánchez Borges, Mario, González Díaz, Sandra Nora, Rosenwasser, Lanny, and Ansotegui, Ignacio J.

Abstract

La Organización Mundial de Alergia (World Allergy Organization) es una federación de sociedades nacionales y regionales de alergia e inmunología clínica cuya misión es promover el desarrollo de estas especialidades a través de programas educativos en congresos, sim- posios y conferencias en diferentes partes del mundo. Esta alianza mundial de sociedades científicas y profesiona- les promueve la excelencia en la atención médica de la población mediante la educación, el entrenamiento y la investigación. Actual- mente 103 Sociedades Nacionales y Regionales de Alergia e Inmu- nología Clínica pertenecen a la Organización Mundial de Alergia

Published
2019

49. GUIMIT 2019, Guía mexicana de inmunoterapia. Guía de diagnóstico de alergia mediada por IgE e inmunoterapia aplicando el método ADAPTE

Author

Larenas Linnemann, Désirée, Luna Pech, Jorge A., Rodríguez Pérez, Noel, Rodríguez González, Mónica, Arias Cruz, Alfredo, Blandón Vijil, María Virginia, Costa Domínguez, María del Carmen, Del Río Navarro, Blanca E., Estrada Cardona, Alan, Navarrete Rodríguez, Elsy Maureen, Ortega Martell, José Antonio, Pozo Beltrán, César Fireth, Brito Díaz, Herson, Canseco Raymundo, María Del Rosario, Castelán Chávez, Enrique Emanuel, Domínguez Silva, Margarita Gabriela, Escalante Domínguez, Alberto José, Gálvez Romero, José Luis, García Reyes, María Guadalupe, Gómez Vera, Javier, González Díaz, Sandra Nora, Guerrero Núñez, María Gracia Belinda, Hernández Colín, Dante Daniel, Macías Weinmann, Alejandra, Mendoza Hernández, David Alejandro, Meneses Sánchez, Néstor Alejandro, Mogica Martínez, María Dolores, Moncayo Coello, Carol Vivian, Montiel Herrera, Manuel, O'Farril Romanillos, Patricia María, Onuma Takane, Ernesto, Ortega Cisneros, Margarita, Rangel Garza, Lorena, Stone Aguilar, Héctor, Torres Lozano, Carlos, Venegas Montoya, Edna, Wakida Kusunoki, Guillermo, Macouzet Sánchez, Carlos, Partida Gaytán, Armando, López García, Aída Inés, Macías Robles, Ana Paola, Ambriz Moreno, María de Jesús, Azamar Jácome, Amyra Ali, Báez Loyola, Carlos, Beltrán de Paz, Claudia Yusdivia, Caballero López, Chrystopherson, Fernández de Córdova Aguirre, Juan Carlos, Fernández Soto, Roberto, Santos Lozano Sáenz, José, Oyoqui Flores, José Joel, Osorio Escamilla, Roberto Efrain, Ramírez, Fernando, Rivero Yeverino, Daniela, Orozco Martínez, María Del Socorro, Rojo Gutiérrez, María Isabel, Martínez, Eric, Medina Ávalos, Miguel Alejandro, Larenas Linnemann, Désirée, Luna Pech, Jorge A., Rodríguez Pérez, Noel, Rodríguez González, Mónica, Arias Cruz, Alfredo, Blandón Vijil, María Virginia, Costa Domínguez, María del Carmen, Del Río Navarro, Blanca E., Estrada Cardona, Alan, Navarrete Rodríguez, Elsy Maureen, Ortega Martell, José Antonio, Pozo Beltrán, César Fireth, Brito Díaz, Herson, Canseco Raymundo, María Del Rosario, Castelán Chávez, Enrique Emanuel, Domínguez Silva, Margarita Gabriela, Escalante Domínguez, Alberto José, Gálvez Romero, José Luis, García Reyes, María Guadalupe, Gómez Vera, Javier, González Díaz, Sandra Nora, Guerrero Núñez, María Gracia Belinda, Hernández Colín, Dante Daniel, Macías Weinmann, Alejandra, Mendoza Hernández, David Alejandro, Meneses Sánchez, Néstor Alejandro, Mogica Martínez, María Dolores, Moncayo Coello, Carol Vivian, Montiel Herrera, Manuel, O'Farril Romanillos, Patricia María, Onuma Takane, Ernesto, Ortega Cisneros, Margarita, Rangel Garza, Lorena, Stone Aguilar, Héctor, Torres Lozano, Carlos, Venegas Montoya, Edna, Wakida Kusunoki, Guillermo, Macouzet Sánchez, Carlos, Partida Gaytán, Armando, López García, Aída Inés, Macías Robles, Ana Paola, Ambriz Moreno, María de Jesús, Azamar Jácome, Amyra Ali, Báez Loyola, Carlos, Beltrán de Paz, Claudia Yusdivia, Caballero López, Chrystopherson, Fernández de Córdova Aguirre, Juan Carlos, Fernández Soto, Roberto, Santos Lozano Sáenz, José, Oyoqui Flores, José Joel, Osorio Escamilla, Roberto Efrain, Ramírez, Fernando, Rivero Yeverino, Daniela, Orozco Martínez, María Del Socorro, Rojo Gutiérrez, María Isabel, Martínez, Eric, and Medina Ávalos, Miguel Alejandro

Published
2019

50. Change in Nasal Airflow, Associated with the Treatment of Rapid Maxillary Expansion in Children with Maxillary Compression

Author

Torre Martínez, Hilda Hortencia Hermelinda, Zertuche de la Fuente, Alejandra, Carrillo González, Roberto José, Theriot Girón, María del Carmen, González Díaz, Sandra Nora, Arias Cruz, Alfredo, Torre Martínez, Hilda Hortencia Hermelinda, Zertuche de la Fuente, Alejandra, Carrillo González, Roberto José, Theriot Girón, María del Carmen, González Díaz, Sandra Nora, and Arias Cruz, Alfredo

Abstract

Purpose: To determine the change of nasal airflow (ANF) in children with maxillary compression after performing rapid expansion treatment. Materials and methods: The sample consisted of 30 patients who attended the Orthodontics Postgraduate Program of the Autonomous University of Nuevo Leon (UANL). They underwent clinical history, study models, lateral cephalogram and orthopantomography. Those who presented maxillary compression were referred to the Regional Center of Allergy and Clinical Immunology (CRAIC) of the University Hospital, UANL., Where a rhinomanometry (T1) was performed to know the values of nasal airflow (NAD) and nasal resistance (RN). before starting the maxillary expansion treatment (ERM). ERM was performed with a Hyrax type expansion screw. Three subsequent registrations were performed with rhinomanometry, the first was one month after starting the ERM (T2), the second to the third month (T3) and the third to the ninth month (T4). Changes in the nasal airflow were compared after of the maxillary rapid expansion, with the student’s t test, with p≤0.05, for related samples. Results: The values of the FAN increased as the measurements were made, on the other hand, the RN decreased progressively. The results were not statistically significant from one time to another. We did not find a statistically significant difference in relation to gender, nor to the present symptomatology. The group of 9 to 10 years was especially favored in relation to the two groups of greater age. Conclusion: The treatment of MRS is an effective treatment to relieve maxillary compression, helps improve nasal capacity, increasing FAN and decreasing the NR; however, it is not recommended in order to improve nasal permeability exclusively.

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results